Regula, J. T., & Koss, M. J. (2016). Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO molecular medicine, 8(11), . https://doi.org/10.15252/emmm.201505889
Chicago Style (17th ed.) CitationRegula, Jörg Thomas, and Michael Janusz Koss. "Targeting Key Angiogenic Pathways with a Bispecific CrossMAb Optimized for Neovascular Eye Diseases." EMBO Molecular Medicine 8, no. 11 (2016). https://doi.org/10.15252/emmm.201505889.
MLA (9th ed.) CitationRegula, Jörg Thomas, and Michael Janusz Koss. "Targeting Key Angiogenic Pathways with a Bispecific CrossMAb Optimized for Neovascular Eye Diseases." EMBO Molecular Medicine, vol. 8, no. 11, 2016, https://doi.org/10.15252/emmm.201505889.
Warning: These citations may not always be 100% accurate.